Abstract
The article investigates the sociocultural implications of the changing modern workplace and of pharmacological cognitive enhancement (PCE) as a potential adaptive tool from the viewpoint of social niche construction. We will attempt to elucidate some of the sociocultural and technological trends that drive and influence the characteristics of this specific niche, and especially to identify the kind of capabilities and adaptations that are being promoted, and to ascertain the capabilities and potentialities that might become diminished as a result. In this context, we will examine what PCE is, and how and why it might be desirable as a tool for adaptation within the workplace. As human beings are, or at least should be allowed to be, more than merely productive, able-bodied and able-minded workers, we will further examine how adaptation to the workplace niche could result in problems in other domains of modern societal life that require the same or other cognitive capabilities. In this context we will also focus on the concept of responsibility and how it pertains to PCE and the modern workplace niche. This will shed some light on the kind of trends related to workplace niche construction, PCE and capability promotion that we can expect in the future, and on the contexts in which this might be either beneficial or detrimental to the individual as a well-rounded human being, and to other members of society.
Similar content being viewed by others
Notes
This is not an attempt to provide any comprehensive summary of all the characteristics and trends that mark the modern workplace, only those that might be most important in connection with performance enhancement, cognitive abilities and PCE. Furthermore, rather than considering all workplaces and professions, we are also focusing mostly on those professions in which the trends of technologization, acceleration and performance enhancement, and the use of PCE, are most evident or likely.
Generally, we can distinguish between three broad and partly overlapping categories of PCE drugs or substances, known as smart drugs, nootropics, cognitive enhancers etc.: (1) prescription drugs (medications) that are used off-label by healthy people; (2) illicit drugs such as cocaine and amphetamines; (3) over-the-counter, commercially available nutritional supplements and products containing caffeine, procognitive substances and plant-based extracts.
References
Roco MC, Bainbridge WS (2003) Converging technologies for improving human performance; nanotechnology, biotechnology, information technology and cognitive science. Springer, Dordrecht
Hughes J (2004) Citizen cyborg. Why democratic societies must respond to the redesigned human of the future. Basic Books, Cambridge, MA
Savulescu J, Bostrom N (eds) (2011) Human enhancement. Oxford University Press, Oxford
Persson I, Savulescu J (2012) Unfit for the future. The need for moral enhancement. Oxford University Press, Oxford
Rosa H, Scheuerman WE (2008) High-speed society. Social acceleration, power, and modernity. Penn State University Press, University Park, PA
Fuller S (2013) Preparing for life in humanity 2.0. Palgrave Macmillan, London
President’s Council on Bioethics (ed) (2008) Human dignity and bioethics. Essays commissioned by the President’s Council on Bioethics. US Independent Agencies and Commissions, Washington/DC
Sandel MJ (2007) The case against perfection. Ethics in the age of genetic engineering. Belknap Press of Harvard University Press, Cambridge, MA
Wolbring G (2008) Ableism, enhancement medicine and the techno poor disabled. In: Healey P, Rayner S (eds) Unnatural selection. The challenges of engineering tomorrow’s people. Earthscan, London, pp 196–209
Lucke J, Partridge B (2013) Towards a smart population. A public health framework for cognitive enhancement. Neuroethics 6:419–427. https://doi.org/10.1007/s12152-012-9167-3
Singh I, Bard I, Jackson J (2014) Robust resilience and substantial interest. A survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PLoS One 9:e105969. https://doi.org/10.1371/journal.pone.0105969
Savulescu J, Meulen R ter, Kahane G (2011) Enhancing human capacities. Wiley-Blackwell, Malden, MA
Bostrom N, Sandberg A (2009) Cognitive enhancement: methods, ethics, regulatory challenges. Sci Eng Ethics 15:311–341. https://doi.org/10.1007/s11948-009-9142-5
Pinker S (1999) How the mind works. Norton, New York
Laland KN, Kendal JR, Brown GR (2007) The niche construction perspective: implications for evolution and human behaviour. J Evol Psychol 5:51–66. https://doi.org/10.1556/JEP.2007.1003
Turkle S (2012) Alone together. Why we expect more from technology and less from each other. Basic Books, New York, NY
Borghino D (2015) Less zen, but more efficient. How the digital age is really affecting our brains. https://newatlas.com/smartphones-attention-span/37559/. Accessed 22 Dec 2017
Brynjolfsson E, McAfee A (2014) The second machine age. Work, progress, and prosperity in a time of brilliant technologies. Norton, New York, NY
Schwab PK (2016) The fourth industrial revolution. World Economic Forum, Cologny/Geneva
Digital Workplace Group (2013) Digital Workplace Fundamentals. https://digitalworkplacegroup.com/resources/download-reports/digital-workplace-fundamentals/. Accessed 22 Dec 2017
Gartner (2018) IT glossary: digital workplace. https://www.gartner.com/it-glossary/digital-workplace/. Accessed 22 Dec 2017
Messenger J, Vargas Llave O, Gschwind L et al (2017) Working anytime, anywhere. The effects on the world of work. Eurofound-ILO, Luxembourg
Cardinali L, Frassinetti F, Brozzoli C, Urquizar C, Roy AC, Farnè A (2009) Tool-use induces morphological updating of the body schema. Curr Biol 19:R478–R479. https://doi.org/10.1016/j.cub.2009.05.009
Fasoli M (2016) Neuroethics of cognitive artifacts. In: Lavazza A (ed) Frontiers in neuroethics. Conceptual and empirical advancements. Cambridge Scholars Publishing, Newcastle upon Tyne, pp 63–75
Carr N (2010) The shallows. What the internet is doing to our brains. Norton, New York, NY
British Academy of Medical Sciences (2012) Human enhancement and the future of work. British Academy of Medical Sciences, London
Schumpeter JA (1994) Capitalism, socialism and democracy. Routledge, London
van Est R, Kool L (2015) Working on the robot society. Visions and insights from science about the relation technology and employment. Rathenau Instituut, The Hague
Frey CB, Osborne MA (2013) The future of employment. How susceptible are jobs to computerization. Technol Forecast Soc Chang 114:254–280
Deloitte LLP (2018) Automation transforming UK industries. https://www2.deloitte.com/uk/en/pages/press-releases/articles/automation-and-industries-analysis.html. Accessed 22 Dec 2017
Susskind RE, Susskind D (2015) The future of the professions. How technology will transform the work of human experts. Oxford University Press, Oxford
European Agency for Safety and Health at Work (2009) OSH in figures: stress at work — facts and figures. https://osha.europa.eu/en/tools-and-publications/publications/reports/TE-81-08-478-EN-C_OSH_in_figures_stress_at_work/view. Accessed 22 Dec 2017
Arnaldi S, Gorgoni G (2016) Turning the tide or surfing the wave? Responsible research and innovation. fundamental rights and neoliberal virtues Life Sciences, Society and. Policy 12(1):6. https://doi.org/10.1186/s40504-016-0038-2
Dale K, Bloomfield B (2015) A review on the future of work: performance-enhancing drugs. https://osha.europa.eu/sites/default/files/seminars/documents/2.%20EU-OSHA%20presentation%20performance%20enhancing%20drugs_0.pdf. Accessed 6 Nov 2018
Committee NB (2013) Neuroscience and pharmacological cognitive enhancement. National Bioethics Committee (Italy), Rome
Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, Farah MJ (2008) Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456:702–705. https://doi.org/10.1038/456702a
British Medical Association (2007) Boosting your brainpower. British Medical Association, London
Franke AG, Bagusat C, Rust S, Engel A, Lieb K (2014) Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur Arch Psychiatry Clin Neurosci 264(Suppl 1):83–90. https://doi.org/10.1007/s00406-014-0537-1
Pustovrh T, Mali F (2014) Exploring some challenges of the pharmaceutical cognitive enhancement discourse. Neuroethics 7:137–158. https://doi.org/10.1007/s12152-013-9192-x
Plante SG (2017) LSD microdoses make people feel sharper, and scientists want to know how. In: The Verge (online), 24 April 2017. https://www.theverge.com/2017/4/24/15403644/microdosing-lsd-acid-productivity-benefits-brain-studies. Accessed 22 Dec 2017
Ilieva IP, Hook CJ, Farah MJ (2015) Prescription stimulants’ effects on healthy inhibitory control, working memory, and episodic memory. A meta-analysis. J Cogn Neurosci 27:1069–1089. https://doi.org/10.1162/jocn_a_00776
Smith ME, Farah MJ (2011) Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull 137:717–741
Partridge BJ, Bell SK, Lucke JC, Yeates S, Hall WD (2011) Smart drugs “as common as coffee”. Media hype about neuroenhancement. PLoS One 6:e28416. https://doi.org/10.1371/journal.pone.0028416
Bagot KS, Kaminer Y (2014) Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth. A systematic review. Addiction 109:547–557
Müller U, Rowe JB, Rittman T, Lewis C, Robbins TW, Sahakian BJ (2013) Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology 64:490–495. https://doi.org/10.1016/j.neuropharm.2012.07.009
Repantis D, Schlattmann P, Laisney O, Heuser I (2010) Modafinil and methylphenidate for neuroenhancement in healthy individuals. A systematic review. Pharmacol Res 62:187–206. https://doi.org/10.1016/j.phrs.2010.04.002
Battleday RM, Brem A-K (2015) Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: a systematic review. Eur Neuropsychopharmacol 25:1865–1881. https://doi.org/10.1016/j.euroneuro.2015.07.028
Wesensten NJ (2006) Effects of modafinil on cognitive performance and alertness during sleep deprivation. Curr Pharm Des 12:2457–2471. https://doi.org/10.2174/138161206777698819
Killgore WDS, Rupp TL, Grugle NL et al (2008) Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. J Sleep Res 17:309–321. https://doi.org/10.1111/j.1365-2869.2008.00654.x
Sauter A, Gerlinger K (2013) The pharmacologically improved human. Performance-enhancing substances as a social challenge. Office of Technology Assessment at the German Parliament (TAB), Berlin. http://www.itas.kit.edu/pub/v/2013/sage13a.pdf Accessed 22 Dec 2017
Farah MJ, Illes J, Cook-Deegan R, Gardner H, Kandel E, King P, Parens E, Sahakian B, Wolpe PR (2004) Neurocognitive enhancement. What can we do and what should we do? Nat Rev Neurosci 5:421–425. https://doi.org/10.1038/nrn1390
Galert T, Bublitz C, Heuser I et al (2009) Das optimierte Gehirn. Gehirn & Geist 11:40–48
Franke AG, Bagusat C, Dietz P, Hoffmann I, Simon P, Ulrich R, Lieb K (2013) Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Med 11(102). https://doi.org/10.1186/1741-7015-11-102
Spillane JF (2000) Cocaine. From medical marvel to modern menace in the United States. John Hopkins University Press, Baltimore, MD, pp 1884–1920
Chase J (2016) How do fighter pilots remain awake in the cockpit? https://vanwinkles.com/how-fighter-pilots-battle-fatigue. Accessed 22 Dec 2017
McLellan TM, Caldwell JA, Lieberman HR (2016) A review of caffeine’s effects on cognitive, physical and occupational performance. Neurosci Biobehav Rev 71:294–312. https://doi.org/10.1016/j.neubiorev.2016.09.001
Harris J (2010) Enhancing evolution. The ethical case for making better people. Princeton University Press, Princeton
Fuller S, Lipinska V (2014) The proactionary imperative. In: A foundation for transhumanism. Palgrave Macmillan, London
Sandberg A, Savulescu J (2014) The social and economic impacts of cognitive enhancement. In: Savulescu J, Meulen R ter, Kahane G (eds) Enhancing human capacities. Wiley-Blackwell, Malden, MA, pp 92–112
Baldi E, Bucherelli C (2005) The inverted “u-shaped” dose-effect relationships in learning and memory. Modulation of arousal and consolidation. Nonlinearity in Biology, Toxicology, and Medicine 3:9–21. https://doi.org/10.2201/nonlin.003.01.002
Hills T, Hertwig R (2011) Why aren’t we smarter already. Evolutionary trade-offs and cognitive enhancements. Curr Dir Psychol Sci 20:373–377. https://doi.org/10.1177/0963721411418300
Huws U (2015) A review of the future of work. Online labour exchanges or ‘crowdsourcing’, implications for occupational safety and health. Discussion Paper. https://osha.europa.eu/sites/default/files/publications/documents/EN-Crowdsourcing_dicussion_paper.pdf. Accessed 6 Nov 2018
Peterkin AL, Crone CC, Sheridan MJ, Wise TN (2011) Cognitive performance enhancement. Misuse or self-treatment? J Atten Disord 15:263–268. https://doi.org/10.1177/1087054710365980
Sattler S, Schunck R (2016) Associations between the big five personality traits and the non-medical use of prescription drugs for cognitive enhancement. Front Psychol 6(1971). https://doi.org/10.3389/fpsyg.2015.01971
Maslen H, Santoni de Sio F, Faber N (2015) With cognitive enhancement comes great responsibility? In: Koops B-J, Oosterlaken I, Romijn H et al (eds) Responsible Innovation 2. Springer, Cham, pp 121–138
Turner DC, Sahakian BJ (2006) Neuroethics of cognitive enhancement. BioSocieties 1:113–123. https://doi.org/10.1017/S1745855205040044
Coenen C, Schuijff M, Smits M et al (2009) Human enhancement. European Parliament, Brussels
Buchanan A (2011) Beyond humanity? The ethics of biomedical enhancement. Oxford University Press, Oxford
Slob M, Staman J (2012) Policy and the evidence beast. A Dutch study of the expectations and practices in the area of evidence-based policy. Rathenau Instituut, The Hague
Arnaldi S, Bianchi L (2016) Responsibility in science and technology. Elements of a social theory. Springer VS, Wiesbaden
Acknowledgements
From Franc Mali and Simone Arnaldi: This is a slightly revised and edited version of the paper presented by our friend and colleague Toni Pustovrh at the Mutual Learning Workshop on “Responsibility and Human Enhancement”, held in Padova (Italy) on 22 May 2017. The workshop was organized within the framework of the research project “Responsibility and Human Enhancement. Concepts, Implications and Assessments” in which Toni participated. The paper was Toni’s final piece of work for the project before he suddenly passed away. We are grateful to Springer, to the journal ‘NanoEthics’ and to its editor Christopher Coenen for agreeing to publish the paper and for their assistance in the publication process. We remember Toni as a gifted young colleague and a dear friend.
Author information
Authors and Affiliations
Corresponding author
Additional information
Tony Pustovrh is deceased
Rights and permissions
About this article
Cite this article
Pustovrh, T., Mali, F. & Arnaldi, S. Are Better Workers Also Better Humans? On Pharmacological Cognitive Enhancement in the Workplace and Conflicting Societal Domains. Nanoethics 12, 301–313 (2018). https://doi.org/10.1007/s11569-018-0332-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11569-018-0332-y